Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Objective Response Rate”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Early research (Phase 1)Study completedNCT01576666
What this trial is testing

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Who this might be right for
Dose EscalationSafetyPreliminary Efficacy+9 more
Novartis Pharmaceuticals 120
Testing effectiveness (Phase 2)UnknownNCT05310383
What this trial is testing

Tislelizumab and Radiotherapy for Recurrent Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaMetastatic Cervical CarcinomaPersistent Cervical Carcinoma+7 more
Lei Li 58
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07591831
What this trial is testing

Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Recurrent Ovarian CancerFallopian Tube CancersEpithelial Ovarian Cancer+1 more
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07150247
What this trial is testing

Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

Who this might be right for
BRAF V600 Colorectal Cancer
Sun Yat-sen University 20
Very early researchEnrolling By InvitationNCT07356466
What this trial is testing

Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric (Stomach) Cancer
Fujian Medical University 100
Not applicableStudy completedNCT05673967
What this trial is testing

Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals 62
Testing effectiveness (Phase 2)Ended earlyNCT05300958
What this trial is testing

Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Sun Yat-sen University 25
Early research (Phase 1)Study completedNCT00481728
What this trial is testing

Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.

Who this might be right for
Overactive Bladder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 28
Testing effectiveness (Phase 2)Looking for participantsNCT06276868
What this trial is testing

Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Henan Cancer Hospital 71
Not applicableWithdrawnNCT07282548
What this trial is testing

Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies

Who this might be right for
Follicular Lymphoma
Ipsen
Testing effectiveness (Phase 2)UnknownNCT04664244
What this trial is testing

Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma

Who this might be right for
Recurrent Cervical CarcinomaRadiotherapyEpidermal Growth Factor Receptor+4 more
Lei Li 43
Very early researchActive Not RecruitingNCT06572956
What this trial is testing

Clinical Study on the Safety and Efficacy of CAR-T/CAR-NK Cells in the Treatment of Recurrent Refractory or Unresectable Solid Tumors

Who this might be right for
Safety and Efficacy of Cellular Drugs, Objective Response Rate of Subjects, Etc
The Second Hospital of Shandong University 10
Testing effectiveness (Phase 2)Study completedNCT04815720
What this trial is testing

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Vaccinex Inc. 49
Not applicableUnknownNCT05755009
What this trial is testing

High- and Low-dose Radiotherapy Combined With Envafolimab for Metastatic Solid Tumor

Who this might be right for
Metastatic Cancer
Jiangxi Provincial Cancer Hospital 33
Testing effectiveness (Phase 2)UnknownNCT05234905
What this trial is testing

H101 Combined With Camrelizumab for Recurrent Cervical Cancer

Who this might be right for
Uterine Cervical NeoplasmsOncolytic VirotherapyCamrelizumab
Zhejiang Cancer Hospital 55
Testing effectiveness (Phase 2)Ended earlyNCT00620100
What this trial is testing

To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent

Who this might be right for
Breast Neoplasms
Sanofi 2
Testing effectiveness (Phase 2)Study completedNCT02366195
What this trial is testing

Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma

Who this might be right for
Unresected Stage IIIb to IVM1c Melanoma
Amgen 112
Testing effectiveness (Phase 2)UnknownNCT01763450
What this trial is testing

Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Liver MetastasesColorectal Cancer
Liaoning Cancer Hospital & Institute 100
Testing effectiveness (Phase 2)UnknownNCT01192230
What this trial is testing

Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Fudan University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06848842
What this trial is testing

Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Liver Metastases
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Load More Results